Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

258.15 +2.77 (+1.08%)

Streaming Delayed Price Updated: 9:43 AM EDT, Sep 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

39 40 Next >

What Does Illumina's Debt Look Like? ↗

January 04, 2023

Shares of Illumina Inc. (NASDAQ:ILMN) moved higher by 1.43% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...

Via Benzinga

Is Illumina Cheap or Expensive? ↗

December 14, 2022

It depends on which numbers you focus on.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

December 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

What 7 Analyst Ratings Have To Say About Illumina ↗

December 07, 2022

Via Benzinga

Looking Into Illumina's Return On Invested Capital ↗

November 21, 2022

Via Benzinga

Genotek (Yerevan, Armenia), Professor Tamara Sarkisian and Illumina open a world-class genomic laboratory

November 18, 2022

The modern laboratory complex, complete with genomic sequencers and microarray analysis platforms from the U.S. company Illumina, helps solve problems in medical research and agriculture. In addition...

Via PRUnderground

Topics Economy

What 12 Analyst Ratings Have To Say About Illumina ↗

November 07, 2022

Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings:

Via Benzinga

11 Analysts Have This to Say About Illumina ↗

November 04, 2022

Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings:

Via Benzinga

This Growth Stock Rose Last Week. Is It Still a Buy? ↗

October 18, 2022

Illumina is the dominant player in gene sequencing.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022 ↗

December 12, 2022

Via Benzinga

GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection

November 17, 2022

From GRAIL, LLC

Via Business Wire

Elon Musk' Lost Millions' Over $8 'Blue Check' Fixation, FTX Hacker Holds $339M In Crypto, Amazon To Cut Workforce Starting This Week: Top Stories Tuesday, Nov. 15 ↗

November 15, 2022

Reuters

Via Benzinga

Illumina Slashes 5% Of Its Workforce ↗

November 15, 2022

Illumina Inc (NASDAQ: ILMN) is cutting 5% of its global workforce to realign its operating expenses to reflect the current macroeconomic environment.

Via Benzinga

Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina ↗

November 14, 2022

Rosenblatt boosted the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $118 to $103. Rosenblatt analyst Barton Crockett maintained the stock with a Neutral rating. Amazon shares fell 4.3% to close...

Via Benzinga

$1000 Invested In Illumina 15 Years Ago Would Be Worth This Much Today ↗

November 10, 2022

Illumina (NASDAQ:ILMN) has outperformed the market over the past 15 years by 8.91% on an annualized basis producing an average annual return of 15.72%. Currently, Illumina has a market capitalization...

Via Benzinga

Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review ↗

November 04, 2022

A mixed jobs report and heavy earnings swung stocks.

Via Investor's Business Daily

Musk Reportedly Suspends Twitter Work On Crypto Wallet, Boeing's Jeppesen Hit By Potential Ransomware Attack, Lyft Cuts Workforce: Top Stories Friday, Nov. 04 ↗

November 04, 2022

Reuters

Via Benzinga

Illumina's Q3 Profits Hit By Impairment Of Almost $4B, Cuts Annual Guidance ↗

November 04, 2022

Via Benzinga

Illumina Plummets On Light Earnings Guidance Despite Quarterly Beat ↗

November 03, 2022

Illumina posted a wide miss for its full-year adjusted earnings outlook, leading shares to tumble after hours.

Via Investor's Business Daily

$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today ↗

November 01, 2022

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 18.98% on an annualized basis producing an average annual return of 26.53%. Currently, Illumina has a market capitalization...

Via Benzinga

Ranking 7 Top Tech Stocks to Buy From Biggest to Smallest ↗

October 28, 2022

Although "Big Tech" is currently struggling, but there are still many good top tech stocks to buy at this point.

Via InvestorPlace

Wall Street Is Still Bullish on This Punished Growth Stock -- Is It a Buy? ↗

October 27, 2022

Bionano's stock price movements have little to do with its successes.

Via The Motley Fool

Illumina Gains But Lags Market: What You Should Know ↗

October 24, 2022

In the latest trading session, Illumina (ILMN) closed at $220.57, marking a +0.25% move from the previous day. This move lagged the S&P 500's daily gain of 1.19%. Meanwhile, the Dow gained 1.34%, and...

Via Talk Markets

Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –

October 18, 2022

This press release was orginally distributed by SBWire

Via ReleaseWire

Companion Diagnostics Industry to Witness Emergence of Players Including Abbott Laboratories, - bioMerieux, Illumina, Agilent Technologies, and Thermo Fisher Scientific –

October 18, 2022

London, UK -- (SBWIRE) -- 10/18/2022 -- The latest publication titled Companion Diagnostics – Thematic Research has been added to GlobalData Plc report store. Companion diagnostics (CDx) are molecular...

Via SBWire

Illumina Inks AI Pact With AstraZeneca To Accelerate Drug Target Discovery ↗

October 11, 2022

Via Benzinga

Universal Sequencing Technology Corporation Announces High-Throughput Solution For NGS Library Preparation

October 24, 2022

UST releases high-throughput solution enabling second-generation short-read sequencers to produce long-range results in greater capacity.CARLSBAD, Calif. - Oct. 24, 2022 - PRLog -- Universal Sequencing...

Via PRLog

Topics Intellectual Property

Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely ↗

October 11, 2022

One analyst doubts any deal could come to fruition. If it did, it would make sense.

Via Investor's Business Daily

Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years ↗

October 06, 2022

Illumina (NASDAQ:ILMN) has outperformed the market over the past 20 years by 19.07% on an annualized basis producing an average annual return of 26.54%. Currently, Illumina has a market capitalization...

Via Benzinga

Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027

October 06, 2022

Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing...

Via FinancialNewsMedia

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Illumina, Inc. - Common Stock (NQ:ILMN)

All News about Illumina, Inc. - Common Stock

Starting at /week.